A high level of CD44 in a tumor correlates with a poor survival prognosis for patients with various cancers, including brain tumors, so it is often considered as a marker of tumor stem cells [30,31,32], although this assumption is questioned by some researchers [33]. This evidence concerns the gene CD44 and neoplasm.